Seven Fleet Capital Management
Seven Fleet Capital Management reported 96 stocks worth $606M in its 13F filing for Q2 2026, filed Aug 17, 2026. Its largest holdings are CGON (22.1%), TNGX (15.8%) and RVMD (7.5%). Compared with Q1 2026, the fund opened new positions in MIRM, MANE and EDIT, added to CGON, TNGX and RVMD, trimmed COGT, RLAY and AGIO and sold out of CGON, TYRA and TNGX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 3 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  CGON CG Oncology Inc | $134M | 22.1% | 1.9M | +1.8M (+2390%) | 3 of 3 | |
| 2 |  TNGX Tango Therapeutics Inc | $95.7M | 15.8% | 3.2M | +2.7M (+543%) | 3 of 3 | |
| 3 |  RVMD Revolution Medicines Inc | $45.3M | 7.5% | 242K | +161K (+200%) | 3 of 3 | |
| 4 |  PHVS Pharvaris N V | $26.8M | 4.4% | 775K | +602K (+348%) | 3 of 3 | |
| 5 |  LQDA Liquidia Corporation | $20.5M | 3.4% | 257K | +69K (+37%) | 3 of 3 | |
| 6 |  ELVN Enliven Therapeutics Inc | $18.5M | 3.1% | 365K | +201K (+123%) | 3 of 3 | |
| 7 |  ABVX Abivax SA | $14.8M | 2.5% | 111K | +68K (+159%) | 3 of 3 | |
| 8 |  AVTX Avalo Therapeutics Inc | $14.2M | 2.4% | 771K | +557K (+260%) | 3 of 3 | |
| 9 |  MIRM Mirum Pharmaceuticals Inc | $12.9M | 2.1% | 110K | New position | 1 of 3 | |
| 10 |  ASMB Assembly Biosciences Inc | $11.9M | 2.0% | 433K | +377K (+671%) | 3 of 3 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CGON CG Oncology Inc | $97.4M | 1.4M |
 TYRA Tyra Biosciences Inc | $7.5M | 196K |
TNGX Tango Therapeutics Inc | $6.3M | 301K |
AVTX Avalo Therapeutics Inc | $5.4M | 360K |
 NERV Minerva Neurosciences Inc | $5.4M | 889K |
🔒 Free account: see all 30.
Reported value
last 3 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 17, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Seven Fleet Capital Management 13F FAQ
What does Seven Fleet Capital Management own?
Seven Fleet Capital Management reported 96 stocks worth $606M in its 13F filing for Q2 2026, filed Aug 17, 2026. Its largest holdings are CGON (22.1%), TNGX (15.8%) and RVMD (7.5%). The table above lists every position in the filing (the top 10 without an account).
What did Seven Fleet Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 24 new positions, 43 added to, 22 trimmed and 43 sold out. New positions include MIRM, MANE and EDIT. It sold all of CGON, TYRA and TNGX.
When will Seven Fleet Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Seven Fleet Capital Management's portfolio worth?
The Q2 2026 filing reports $606M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.